JP2024504637A5 - - Google Patents
Info
- Publication number
- JP2024504637A5 JP2024504637A5 JP2023542885A JP2023542885A JP2024504637A5 JP 2024504637 A5 JP2024504637 A5 JP 2024504637A5 JP 2023542885 A JP2023542885 A JP 2023542885A JP 2023542885 A JP2023542885 A JP 2023542885A JP 2024504637 A5 JP2024504637 A5 JP 2024504637A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- hydrogen
- heterocycloalkyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163199694P | 2021-01-18 | 2021-01-18 | |
| US63/199,694 | 2021-01-18 | ||
| PCT/US2022/012831 WO2022155614A1 (en) | 2021-01-18 | 2022-01-18 | Synthetic ursolic acid derivatives and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024504637A JP2024504637A (ja) | 2024-02-01 |
| JP2024504637A5 true JP2024504637A5 (https=) | 2025-01-27 |
Family
ID=80222334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542885A Pending JP2024504637A (ja) | 2021-01-18 | 2022-01-18 | 合成ウルソール酸誘導体及びその使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240140986A1 (https=) |
| EP (1) | EP4277916A1 (https=) |
| JP (1) | JP2024504637A (https=) |
| KR (1) | KR20230147077A (https=) |
| CN (1) | CN117015548A (https=) |
| AU (1) | AU2022208727A1 (https=) |
| CA (1) | CA3204434A1 (https=) |
| CL (1) | CL2023002064A1 (https=) |
| CO (1) | CO2023010422A2 (https=) |
| IL (1) | IL304530A (https=) |
| MX (1) | MX2023008454A (https=) |
| PE (1) | PE20231661A1 (https=) |
| TW (1) | TW202245795A (https=) |
| WO (1) | WO2022155614A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121794280A (zh) * | 2023-07-28 | 2026-04-03 | 里亚塔医药控股有限责任公司 | 用于制备三萜类衍生物的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0907423A2 (pt) | 2008-01-11 | 2020-10-27 | Reata Pharmaceuticals, Inc. | composto triterpenoide sintético para uso em um método de melhoria da função renal em um indivíduo, e uso do referido composto |
| MX2010011439A (es) | 2008-04-18 | 2011-01-25 | Reata Pharmaceuticals Inc | Moduladores de inflamacion antioxidantes: derivados del acido oleanolico homologacion c-17. |
| JP5529851B2 (ja) | 2008-04-18 | 2014-06-25 | リアタ ファーマシューティカルズ インコーポレイテッド | 抗酸化炎症モジュレーター：ｃ−１７においてアミノ改変およびその他の改変を加えたオレアノール酸誘導体 |
| KR101713140B1 (ko) * | 2008-04-18 | 2017-03-08 | 리타 파마슈티컬스 잉크. | Ｃ-환에서 포화된 산화방지성 염증 조절제 올레아놀산 유도체 |
| US8071632B2 (en) | 2008-04-18 | 2011-12-06 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| MX348862B (es) | 2011-03-11 | 2017-07-03 | Reata Pharmaceuticals Inc | Derivados c4-monometil triterpenoides y sus metodos de uso. |
| TWI623548B (zh) * | 2012-04-27 | 2018-05-11 | 瑞塔醫藥有限責任公司 | 齊墩果酸（ｂａｒｄｏｘｏｌｏｎｅ ｍｅｔｈｙｌ）之２，２-二氟基丙醯胺衍生物、多晶型及其使用方法 |
| WO2013188818A1 (en) * | 2012-06-15 | 2013-12-19 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
| JP6243428B2 (ja) * | 2012-09-10 | 2017-12-06 | リアタ ファーマシューティカルズ インコーポレイテッド | オレアノール酸のｃ１７−アルカンジイルおよびアルケンジイル誘導体ならびにその使用方法 |
| US9512094B2 (en) | 2012-09-10 | 2016-12-06 | Reata Pharmaceuticals, Inc. | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
| SMT201700501T1 (it) | 2012-09-10 | 2017-11-15 | Reata Pharmaceuticals Inc | Derivati c17-eteroarilici dell'acido oleanolico e metodi d'uso degli stessi |
| AR096046A1 (es) * | 2013-04-24 | 2015-12-02 | Abbvie Inc | Derivados de 2,2-difluoropropanamida de metil bardoxolona, formas polimórficas y métodos de uso |
| JP7074674B2 (ja) * | 2015-09-23 | 2022-05-24 | リアタ ファーマシューティカルズ インコーポレイテッド | Ｉｌ－１７の阻害及び他の使用のためのｃ４修飾オレアノール酸誘導体 |
| CN110198718B (zh) * | 2016-11-08 | 2023-01-10 | 里亚塔医药控股有限责任公司 | 使用甲基巴多索隆或其类似物治疗阿尔波特综合征的方法 |
| MX2021003643A (es) * | 2018-09-28 | 2021-08-19 | Sichuan Haisco Pharmaceutical Co Ltd | Derivados de terpenoides y usos de los mismos. |
-
2022
- 2022-01-18 MX MX2023008454A patent/MX2023008454A/es unknown
- 2022-01-18 JP JP2023542885A patent/JP2024504637A/ja active Pending
- 2022-01-18 US US18/261,732 patent/US20240140986A1/en active Pending
- 2022-01-18 AU AU2022208727A patent/AU2022208727A1/en active Pending
- 2022-01-18 EP EP22703206.7A patent/EP4277916A1/en active Pending
- 2022-01-18 TW TW111102086A patent/TW202245795A/zh unknown
- 2022-01-18 CN CN202280019965.8A patent/CN117015548A/zh active Pending
- 2022-01-18 KR KR1020237028003A patent/KR20230147077A/ko active Pending
- 2022-01-18 PE PE2023002112A patent/PE20231661A1/es unknown
- 2022-01-18 CA CA3204434A patent/CA3204434A1/en active Pending
- 2022-01-18 WO PCT/US2022/012831 patent/WO2022155614A1/en not_active Ceased
-
2023
- 2023-07-14 CL CL2023002064A patent/CL2023002064A1/es unknown
- 2023-07-17 IL IL304530A patent/IL304530A/en unknown
- 2023-08-09 CO CONC2023/0010422A patent/CO2023010422A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI884403B (zh) | 抗病毒化合物 | |
| CN103619866B (zh) | C4-一甲基三萜系化合物的衍生物及其使用方法 | |
| US6255453B1 (en) | Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors | |
| US8809539B2 (en) | Dicarboxylic acid derivatives as S1P1 receptor agonists | |
| CN109476705B (zh) | 新型环孢菌素衍生物及其用途 | |
| JP4342437B2 (ja) | 興奮性アミノ酸のプロドラッグ | |
| PT96234A (pt) | Agentes inibidores da protease de hiv uteis no tratamento da sida | |
| JP2024050607A (ja) | 結晶性の置換シクロヘキシルピラゾロ［１，５－ａ］ピリミジニルカルボキサミド化合物およびその治療的使用 | |
| WO2013188818A1 (en) | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof | |
| JPH06503568A (ja) | Ｈｉｖプロテアーゼ阻害剤 | |
| WO2014053595A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
| CA2749840A1 (en) | Novel eicosanoid derivatives | |
| JP2024504637A5 (https=) | ||
| HUT67374A (en) | Process for producing hexahydropyridazine carboxylic acid derivatives and pharmaceutical compositions containing them | |
| WO2013020245A1 (en) | Carbonyl derivatives of betulin | |
| WO2018171688A1 (en) | Atf3 induction compounds | |
| JP2023507402A5 (https=) | ||
| CA2934964C (en) | Novel cyp-eicosanoid derivatives | |
| GB2374595A (en) | Fused bicyclic or tricyclic amino acids | |
| JPH07508748A (ja) | ヒト白血球エラスターゼに対する阻害剤としてのフッ素含有ジペプチド | |
| US8063037B2 (en) | Progesterone receptor modulators | |
| ES2704056T3 (es) | Compuestos de epoxicetona para la inhibición de enzimas | |
| AU2008248873B2 (en) | New progesterone receptor modulators | |
| WO2026026869A1 (zh) | 可离子化脂质及其用途 | |
| CN104496839B (zh) | 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途 |